Pellegatta, S.; Di Ianni, N.; Pessina, S.; Paterra, R.; Anghileri, E.; Eoli, M.; Finocchiaro, G.
ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy. Int. J. Mol. Sci. 2019, 20, 5886.
https://doi.org/10.3390/ijms20235886
AMA Style
Pellegatta S, Di Ianni N, Pessina S, Paterra R, Anghileri E, Eoli M, Finocchiaro G.
ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy. International Journal of Molecular Sciences. 2019; 20(23):5886.
https://doi.org/10.3390/ijms20235886
Chicago/Turabian Style
Pellegatta, Serena, Natalia Di Ianni, Sara Pessina, Rosina Paterra, Elena Anghileri, Marica Eoli, and Gaetano Finocchiaro.
2019. "ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy" International Journal of Molecular Sciences 20, no. 23: 5886.
https://doi.org/10.3390/ijms20235886
APA Style
Pellegatta, S., Di Ianni, N., Pessina, S., Paterra, R., Anghileri, E., Eoli, M., & Finocchiaro, G.
(2019). ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy. International Journal of Molecular Sciences, 20(23), 5886.
https://doi.org/10.3390/ijms20235886